ELTD1 has been previously detected in the plasma of breast cancer patients using Liquid Chromatography‐Electrospray Ionization‐Mass Spectroscopy (LC‐ESI‐MS) (Dufresne et al., 2019). The gene discussed is ADGRL4; the disease is breast carcinoma.